Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:
Quiring, Courtney, et al. "Efalizumab." Davis's Drug Guide, 16th ed., F.A. Davis Company, 2019. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51823/all/efalizumab.
Quiring C, Sanoski CA, Vallerand AH. Efalizumab. Davis's Drug Guide. 16th ed. F.A. Davis Company; 2019. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51823/all/efalizumab. Accessed October 17, 2019.
Quiring, C., Sanoski, C. A., & Vallerand, A. H. (2019). Efalizumab. In Davis's Drug Guide. Available from https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51823/all/efalizumab
Quiring C, Sanoski CA, Vallerand AH. Efalizumab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2019. [cited 2019 October 17]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51823/all/efalizumab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - efalizumab
ID - 51823
A1 - Quiring,Courtney,
AU - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51823/all/efalizumab
PB - F.A. Davis Company
ET - 16
DB - Medicine Central
DP - Unbound Medicine